BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37956408)

  • 1. Functional assay for assessment of pathogenicity of BAP1 variants.
    Repo PE; Backlund MP; Kivelä TT; Turunen JA
    Hum Mol Genet; 2024 Feb; 33(5):426-434. PubMed ID: 37956408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based analysis of BAP1 germline variations in patients with uveal melanoma.
    Repo P; Järvinen RS; Jäntti JE; Markkinen S; Täll M; Raivio V; Turunen JA; Kivelä TT
    Hum Mol Genet; 2019 Jul; 28(14):2415-2426. PubMed ID: 31058963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.
    Walpole S; Pritchard AL; Cebulla CM; Pilarski R; Stautberg M; Davidorf FH; de la Fouchardière A; Cabaret O; Golmard L; Stoppa-Lyonnet D; Garfield E; Njauw CN; Cheung M; Turunen JA; Repo P; Järvinen RS; van Doorn R; Jager MJ; Luyten GPM; Marinkovic M; Chau C; Potrony M; Höiom V; Helgadottir H; Pastorino L; Bruno W; Andreotti V; Dalmasso B; Ciccarese G; Queirolo P; Mastracci L; Wadt K; Kiilgaard JF; Speicher MR; van Poppelen N; Kilic E; Al-Jamal RT; Dianzani I; Betti M; Bergmann C; Santagata S; Dahiya S; Taibjee S; Burke J; Poplawski N; O'Shea SJ; Newton-Bishop J; Adlard J; Adams DJ; Lane AM; Kim I; Klebe S; Racher H; Harbour JW; Nickerson ML; Murali R; Palmer JM; Howlie M; Symmons J; Hamilton H; Warrier S; Glasson W; Johansson P; Robles-Espinoza CD; Ossio R; de Klein A; Puig S; Ghiorzo P; Nielsen M; Kivelä TT; Tsao H; Testa JR; Gerami P; Stern MH; Paillerets BB; Abdel-Rahman MH; Hayward NK
    J Natl Cancer Inst; 2018 Dec; 110(12):1328-1341. PubMed ID: 30517737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
    Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
    BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two unique BAP1 pathogenic variants identified in the same family by panel cascade testing.
    Byrne L; Ingalls C; Ansari A; Porteus C; Donenberg TR; Sussman DA; Cebulla CM; Abdel-Rahman MH
    Fam Cancer; 2023 Jul; 22(3):307-311. PubMed ID: 36513904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population-based analysis of germline BAP1 mutations in melanoma.
    O'Shea SJ; Robles-Espinoza CD; McLellan L; Harrigan J; Jacq X; Hewinson J; Iyer V; Merchant W; Elliott F; Harland M; Bishop DT; Newton-Bishop JA; Adams DJ
    Hum Mol Genet; 2017 Feb; 26(4):717-728. PubMed ID: 28062663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BAP1 Syndrome - Predisposition to Malignant Mesothelioma, Skin and Uveal Melanoma, Renal and Other Cancers.
    Foretová L; Navrátilová M; Svoboda M; Házová J; Vašíčková P; Sťahlová EH; Fabian P; Schneiderová M; Macháčková E
    Klin Onkol; 2019; 32(Supplementum2):118-122. PubMed ID: 31409087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinomas developing independently from BAP1-tumor predisposition syndrome in a patient with bilateral uveal melanoma: Diagnostic challenges to identify patients with BAP1-TPDS.
    Melzer C; Sharma A; Peters S; Aretz S; Biswas A; Holz FG; Loeffler KU; Herwig-Carl MC
    Genes Chromosomes Cancer; 2019 Jun; 58(6):357-364. PubMed ID: 30578689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Re-evaluating the pathogenicity of the c.783+2T>C BAP1 germline variant.
    Goldberg Y; Laitman Y; Ben David M; Bazak L; Lidzbarsky G; Salmon LB; Shkedi-Rafid S; Barshack I; Avivi C; Darawshe M; Shomron N; Bruchim R; Vinkler C; Yannoukakos D; Fostira F; Bernstein-Molho R; Friedman E
    Hum Mutat; 2021 May; 42(5):592-599. PubMed ID: 33600035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases.
    Pilarski R; Cebulla CM; Massengill JB; Rai K; Rich T; Strong L; McGillivray B; Asrat MJ; Davidorf FH; Abdel-Rahman MH
    Genes Chromosomes Cancer; 2014 Feb; 53(2):177-82. PubMed ID: 24243779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers.
    Abdel-Rahman MH; Pilarski R; Cebulla CM; Massengill JB; Christopher BN; Boru G; Hovland P; Davidorf FH
    J Med Genet; 2011 Dec; 48(12):856-9. PubMed ID: 21941004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of uveal melanomas and paired constitutional DNA for exclusion of a BAP1-tumor predisposition syndrome.
    Abbassi YA; Le Guin C; Bornfeld N; Bechrakis NE; Zeschnigk M; Lohmann DR
    Fam Cancer; 2023 Apr; 22(2):193-202. PubMed ID: 35920959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia.
    Gupta S; Erickson LA; Lohse CM; Shen W; Pitel BA; Knight SM; Halling KC; Herrera-Hernandez L; Boorjian SA; Thompson RH; Leibovich BC; Jimenez RE; Cheville JC
    JAMA Netw Open; 2021 Nov; 4(11):e2132615. PubMed ID: 34767027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAP1 germline variants in Finnish patients with malignant mesothelioma.
    Repo P; Staskiewicz A; Sutinen E; Rönty M; Tero T Kivelä ; Myllärniemi M; Turunen JA
    Lung Cancer; 2022 Mar; 165():102-107. PubMed ID: 35114507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAP1 Germline Mutations in Finnish Patients with Uveal Melanoma.
    Turunen JA; Markkinen S; Wilska R; Saarinen S; Raivio V; Täll M; Lehesjoki AE; Kivelä TT
    Ophthalmology; 2016 May; 123(5):1112-7. PubMed ID: 26876698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
    Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
    Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAP1 germline mutation in two first grade family members with uveal melanoma.
    Maerker DA; Zeschnigk M; Nelles J; Lohmann DR; Worm K; Bosserhoff AK; Krupar R; Jägle H
    Br J Ophthalmol; 2014 Feb; 98(2):224-7. PubMed ID: 24187051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations.
    Zauderer MG; Jayakumaran G; DuBoff M; Zhang L; Francis JH; Abramson DH; Cercek A; Nash GM; Shoushtari A; Chapman P; D'Angelo S; Arnold AG; Siegel B; Fleischut MH; Ni A; Rimner A; Rusch VW; Adusumilli PS; Travis W; Sauter JL; Zehir A; Mandelker D; Ladanyi M; Robson M
    J Thorac Oncol; 2019 Nov; 14(11):1989-1994. PubMed ID: 31323388
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.